Literature DB >> 15752874

A challenge to the therapeutic nihilism of ESPAC-1.

Mary C Koshy, Jerome C Landry, Sean X Cavanaugh, Clifton D Fuller, Christopher G Willett, Ross A Abrams, John P Hoffman, Charles R Thomas.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15752874     DOI： 10.1016/j.ijrobp.2004.11.018

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  17 in total

1.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

2.  Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database.

Authors:  Arya Amini; Bernard L Jones; Priscilla Stumpf; Stephen Leong; Christopher H Lieu; Colin Weekes; S Lindsey Davis; Wells A Messersmith; William T Purcell; Debashis Ghosh; Tracey Schefter; Karyn A Goodman
Journal:  Pancreas       Date:  2017-08       Impact factor: 3.327

3.  The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.

Authors:  William A Hall; Lauren E Colbert; Yuan Liu; Theresa Gillespie; Joseph Lipscomb; Claire Hardy; David A Kooby; Roshan S Prabhu; John Kauh; Jerome C Landry
Journal:  Cancer       Date:  2013-04-26       Impact factor: 6.860

Review 4.  Pancreatic cancer.

Authors:  Audrey Vincent; Joseph Herman; Rich Schulick; Ralph H Hruban; Michael Goggins
Journal:  Lancet       Date:  2011-05-26       Impact factor: 79.321

Review 5.  Adjuvant therapy in pancreatic cancer: a critical appraisal.

Authors:  Helmut Oettle; Peter Neuhaus
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.

Authors:  Jona A Hattangadi; Theodore S Hong; Beow Y Yeap; Harvey J Mamon
Journal:  Cancer       Date:  2009-08-15       Impact factor: 6.860

Review 7.  Diagnosis and management of pancreatic cancer.

Authors:  A Collins; M Bloomston
Journal:  Minerva Gastroenterol Dietol       Date:  2009-12

Review 8.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

9.  Adjuvant treatment.

Authors:  Asma Sultana; John Neoptolemos; Paula Ghaneh
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.